Search results

A potentially attractive way for cities to maintain economic growth while reducing environmental harm is to let their production structures undergo industrial transformation, a process otherwise known as ecological modernization. This attraction lies mainly in the fact that residents, visitors and corporations prefer clean air, water and soil as a milieu to invest their resources in. Municipal governments can use city branding as an important instrument to force off such a transformation, if it is taken as a point of departure for the adoption of a strategy to which they are deeply committed and for the benefit of which they are willing to deploy their various policy instruments. In the literature on ecological modernization, five different pathways for industrial transformation in cities have been identified and these have been matched with city branding practices. In this contribution, the abovementioned conceptual framework is further detailed and specified to account for a variety in types of secondary and tertiary sector industries. In the empirical sections, all cities in the Chinese provinces Hubei and Hunan, where the transition from manufacturing to services is typically most pressing, are examined in terms of their industrial structures, pathways to industrial transformation and city branding choices. The results indicate, inter alia, that further subdivision of the secondary and tertiary economic sectors is useful in understanding key features of the transformation, and that different sub-pathways affect tradeoffs between economic expansion and ecological preservation differently. Branding practices among Hubei and Hunan cities also indicate that some industries are more easily embraced and utilized than others in establishing brand identities and adopting popular city labels.

Anti-Retroviral Therapy (ART) is the recommended first line therapy for patients with HIV. Since 2004, Chinese government has provided free Chinese herbal medicine (CHM) for Chinese HIV/AIDS patients. Data of living patients with HIV from the NFTCMP database and Center for Disease Control (CDC) database during 2003-2016 in Guangxi province was obtained and compared. Patients were divided into 3 groups according to their recorded treatment regimens. A total of 2954 patients with their treatment recorded in the two databases were included for analysis, their median age was 46 years (IQR = 36-59), and 64.63% were male. CHM regimens users had baseline CD4 cell counts (380.11±240.59 cell/μL), approximately 100 cell/μL significantly higher than patients receiving CHM combined with ART regimens or only ART regimens. There was no significant difference in mortality among groups. All three regimens improved patients' CD4 cell counts. Compared to the sharp improvement in ART group during the first 6 months, CD4 cell counts of patients in CHM group and CHM combined with ART group showed a smooth and steady rise. CD4 counts of the combined group remained much lower than ART group in the first 3 years, but overtook ART group in the fourth year.